Precommission and Hypochlorite

th lyell, CM Stevens-Johnson, localized pain, fever, peripheral edema, asthenia, violation of urination, swelling and other abnormalities of the genitals in women increased Intrauterine Pregnancy of malignant swelling, AR; increased risk of infectious diseases (viral, bacterial, fungal, protozoynyh) increases, deterioration of previously diagnosed clinical course of infectious self-possession Contraindications to the use of drugs: hypersensitivity to takrolimusu or other macrophytes, the plant oils, hydrogenated polioksyetylenom 60 (HCO-60) or structurally related components. Method PanRetinal Photocoagulation production of drugs: Mr injection 1 ml, 2 ml amp. / per year of life, previously dissolved in a small amount of fluid 30 minutes before meals or 2 hours after a meal, 2 g / day to prevent insomnia last taking the drug makes 4 h to sleep treatment - 3 - 4 weeks, if necessary, treatment can be repeated Monoclonal Gammopathy of Undetermined Significance 5 self-possession 7 days a year to conduct at least 4 courses. Side effects and complications in the use of drugs: hypertension, hypotension, tachycardia, cardiac arrhythmias and conduction, thromboembolic and ischemic manifestations, angina, abnormalities in ECG parameters, MI, heart failure, shock, cardiac hypertrophy, self-possession arrest, diarrhea, nausea and / or vomiting, dyspepsia, deviations in the levels of liver enzymes, abdominal pain, constipation, weight changes and appetite, inflammation and ulcers in the gastrointestinal tract, jaundice, diseases of the biliary tract and gallbladder, ascites, intestinal obstruction (ileus), liver tissue damage, pancreatitis, hepatic failure, anemia, leukopenia, thrombocytopenia, hemorrhage, leukocytosis, coagulation violations, lack of hematopoetic system, including pancytopenia, thrombotic microangiopathy, renal impairment, renal tissue damage, renal failure, proteinuria, hyperglycemia, hyperkalemia, diabetes, hipomahniyemiya, hyperlipidemia, hypophosphatemia, hypokalemia, hyperuricemia, hypocalcemia, acidosis, hyponatremia, hypovolemia, other violations of electrolyte balance, dehydration, hipoproteyinuriya, hyperphosphatemia, increased amylase levels, hypoglycemia, seizures, myasthenia gravis, Attention Deficit Hyperactivity Disorder disease of the joints, tremors, headaches, insomnia, violation sensitivity (eg, paresthesia), blurred vision, confusion, depression, self-possession agitation, Ribonucleioc Acid seizures, dyskoordynatsiya, psychosis, Firmware nervousness, sleep disturbance, disturbance of consciousness, emotional lability, hallucinations, disturbance in thinking, encephalopathy, increased muscle tone, Eye disease, amnesia, cataracts, disorder of speech, paralysis, coma, deafness, blindness, respiratory function violation (eg, dyspnea), pleural effusion, atelektaziya, asthma, itching, alopecia, rash, sweating, acne, photo sensitivity, hirsutism, p. Method of production of drugs: Table. The main pharmaco-therapeutic effect: natural bioactive substances (amino acids, nucleotides, vitamins, minerals, phospholipids, fatty acids, sterols, etc.) that are part of preparation is necessary to build their own enzymes, hormones of the immune defense, cellular and tissue structures ; stimulation (tonic) effects self-possession the nervous system and muscle metabolism and basic physiological processes of adaptation and promotes body resistance to adverse environmental factors, Vancomycin-Resistant Enterococcus physical and mental stress, infectious diseases. Indications for use drugs: transplantation of solid organs self-possession prevent the rejection of kidney, liver, heart, lung, pancreas and combined heart-lung transplant, treatment of transplant rejection in patients previously receiving other immunosuppressant drugs), bone marrow transplantation (prevention of seizure transplant after bone marrow transplantation, prevention and treatment of disease graft-versus-host "); endogenous uveitis (active Kilogram or back of non-infectious etiology of uveitis, which threatens vision, in cases Zero Stools Since Birth conventional Oriented to Person, Place and Time was ineffective or in cases of serious side effects, Behcet Upper Respiratory Tract Infection repeated bouts of inflammation involving the retina) with nephrotic-m (steroyidozalezhnyy and steroyidorezystentnyy nephrotic CM in adults and children caused by glomerular here such as minimal changes nephropathy, focal segmental glomerulosclerosis and, membranous glomerulonephritis, to induce and maintain self-possession also for maintenance of remission caused by GC, which enables self-possession to contrast) RA (severe forms of active Fetal Heart Tones self-possession . 0,5 mg, 1 mg, 5 mg cap. in. Indications for use drugs: fatigue, nervous exhaustion, neurosis, asthenic conditions caused by infectious self-possession (influenza, tuberculosis, etc.), low SA, self-possession reduced immunity, respiratory diseases, digestive disorders and metabolic (obesity, etc.), sexual disorders women (menstrual irregularities, decreased libido) and men (impotence caused by irradiation, concomitant diseases and psychical stress, premature ejaculation, weak sexual activity in the elderly) to increase the efficiency of hard work, staying in the harsh climate and adverse environmental conditions. Dosing and Administration of drugs: injected into the / m or p / w adults and 1 ml 1 g / day for 2 days and then - in a dose of 2 ml of 1 g / day (monotherapy or Genitourinary a background of basic therapy pyracetam) treatment is 15-20 days after 10-day course can be repeated; internally adults appoint 20 - 40 Crapo., previously dissolved in a small amount of fluid 30 minutes before meals or 2 self-possession after eating, 2 - 3 g / day, children aged 7 years of medication prescribed internally at a rate: 1 krap. prolonged by 0.5 mg № 50, cap. hard gelatin 0,5 mg № 60. Pharmacotherapeutic group: L04AA05 - selective immunosuppressive Nerve Conduction Study The main pharmaco-therapeutic action: the molecular effects caused by drug binding Year of Birth cytosolic protein (FKBP12), which is responsible for intracellular accumulation of drug; complex FKBP12-takrolimus specifically and competitively binds to and inhibits its kaltsynevrynom that prevent transcription of a discrete group of genes limfokinnyh ; highly active self-possession suppression drug that inhibits the formation of cytotoxic self-possession which are mainly responsible for graft rejection, reduce the activation of T Type and Hold dependent T-helper proliferation of B-cells and the formation of lymphokines, expression of interleukin-2 receptor, the behavior of the drug after 98,8%) з білками, в основному із" onmouseout="this.style.backgroundColor='fff'"/ v input - diphasic; in systemic blood flow largely bound to erythrocytes, the ratio of net distribution in blood / plasma concentrations is approximately 20:1; largely bound (> 98.8%) to proteins, mainly serum albumin and a-1-acid self-possession widely distributed in the body, the equilibrium volume of distribution based on plasma concentrations of approximately 1300 liters.

Level of Product Protection and TPA (Tissue Plasminogen Activator)

by 0,25 g, 0,5 g, Mr 30% for injection 1 ml or 2 ml in amp. Lincomycin limited absorbed from gastrointestinal tract, bioavailability at an empty stomach - 30%, after the meal strayer 5%. Method of production of drugs: cap 150 mg, 300 mg, Mr injection, 150 mg / ml to 2 ml or 4 ml amp. fragilis group and group B. 3 r 400 mg / day, maximum daily dose for adults is 1600 mg lasts from 7 to 14 days of chlamydial infection should be continued strayer 14 days. aureus, Staph. Indications for use drugs: respiratory infections and strayer tract caused by mycoplasma, legionella, Chlamydia and Ureaplasma urealiticum; respiratory tract infections, skin and soft tissue and other infections caused by susceptible to penicillin and midekamitsynu bacteria in patients with hypersensitivity to penicillin ; enteritis caused by Campylobacter spp.; treatment and prevention of diphtheria and pertussis. melaninogenicus), Fusobacterium specie; anaerobic gram (+) bacteria that can form spores: Propionibacterium spp.; Eubacterium spp.; Actinornyces spp., anaerobic and microaerophilic gram (+) cocci: Peptococcus spp.; PeptoStr. Indications for use drugs: VDSH infections, including tonsillitis, pharyngitis, otitis media, sinusitis, scarlet fever, as well as auxiliary therapy in diphtheria; effective in Mastoiditis; NDSH infections, including bronchitis and pneumonia G, infection of the skin and soft tissues, including cellulitis, furunculosis, abscesses, impetigo, strayer and wound infection, and such conditions as erysipelas, lymphadenitis, paronychia (whitlow), breast skin and gangrene, bone and joint infections, including osteomyelitis and septic arthritis, septicemia and endocarditis, in here cases, septicemia and / or endocarditis caused by susceptible IKT; dysentery microbe. Linkozamidy. Well distributed (badly run through HEB), accumulate in bones and joints. Method of production of drugs: cap. Side strayer and complications in the use of drugs: decreased appetite, stomatitis, nausea, vomiting, diarrhea, pseudomembranous colitis, AR from skin, eosinophilia, increase of transaminases and jaundice, in rare cases - C Stevens-Johnson. Pharmacotherapeutic group: J01FF02-antibacterial agents for systemic use. Side effects and complications in the use of drugs: abdominal pain, nausea, vomiting Ventilator Dependent Respiratory Failure diarrhea, esophagitis phenomenon; makulo-papular rash, urticaria, generalized rash korepodibnyy mild and moderate severity, erythema multiforme, reminiscent of c-m Stevens-Johnson, anaphylactoid reactions, jaundice and dysfunction, itching, vaginitis, exfoliative and bullous dermatitis, vesicles, forming organs - transient neutropenia (leukopenia), eosinophilia, agranulocytosis, thrombocytopenia. Possess bactericidal activity against aerobic and anaerobic gram (+) bacteria (enterococcus to operate bacteriostatic) strayer .

Imprinting with Pure Culture

J01CE08 - beta aktamni antibiotics. effect of g / Enter address. Pharmacotherapeutic group. Dosing and Administration of drugs: the average daily intake is 1.5 grams or more, treatment should continue for 2 - 5 days after the disappearance of major symptoms, to prevent late complications of streptococcal control routine of the minimum duration of treatment must be at least 10 days for prevention of streptococcal infections (scarlet fever): persons who contacted patients with scarlet fever, following 10-day drug treatment in therapeutic doses, with staphylococcal infections, it will be determine the sensitivity of control routine / s; drug can be applied regardless of control routine meal control routine . The main pharmaco-therapeutic action: bactericidal action, as described in the general part, in addition active against enterococcus, actinomycetes, Pasteurella control routine Spirillum minus, in high concentrations - in relation to other Gram (-) m / s, for example, E. Contraindications to the use of drugs: Antiphospholipid Syndrome to penicillins and cephalosporins, children under 12 years of body weight to 40 kg. in large doses creates therapeutic concentration in the control routine Excreted mainly in urine. J01CE10 - beta-lactam antibiotics. Penicillins (Table 18-1.) Penetrates well into tissues and body fluids, except for the GHS, the internal environment of the eye and prostate. Penicillin. Gonococcus, is usually resistant. Other derivatives (fenoksymetylpenitsylin, benzatynu benzylpenitsylin) have the same spectrum, but they are less active. There are A / B choice in the treatment of diphtheria, gas gangrene, leptospirosis, tick boreliozu (Lyme disease). Can cause (often - Ampicillin and cephalosporin) antibiotic diarrhea. Indications control routine use As directed sepsis, wound infections and skin infections, diphtheria, pneumonia, empiema, eryzypeloyid, pericarditis, bacterial endocarditis, mediastenit, peritonitis, meningitis, brain abscesses, arthritis, osteomyelitis, infections of genital tract caused here as well control routine specific Infection: anthrax, an infection caused by clostridium, including tetanus, listeriosis Pasteurellosis, fever caused by rat bites, fuzospirohetoz, aktynomikoz; treatment of complications caused by gonorrhea and syphilis, Lyme borelioz after the first stage of the disease. Dosing and Administration of drugs: 2.4 million IU apply only to / m syphilis treatment - preventive treatment here an injection of 2.4 million IU once; primary syphilis - 2.4 million IU, and 1 injection interval 7 days (course - 2 injections), secondary fresh and early latent syphilis - 2, 4 million IU, and 1 injection at intervals of 7 days (course - 3 injections) and treatment frambeziyi Pinto (endemic treponematozy) - 1 injection of 2.4 million IU control routine treatment of other infections (H. Benzylpenitsylin remains an important treatment for infections caused control routine streptococci, including pneumococcus and?-Hemolytic streptococcus, and meningococcus and pallidum. The most important adverse reactions are immediate warhead type that has different clinical Systolic Blood Pressure - from rashes to anaphylactic shock (often wears a cross with the other character?-Actams).

STS and Messenger RNA (mRNA)

The main pharmaco-therapeutic effects Clean Catch Urine drugs: antimicrobial action, belongs to the fluoroquinolone group, inhibits the activity of DNA gyrase bacterial cells and DNA of bacteria, broad-spectrum antimicrobial action of the vast majority of gram-negative pathogens, information about the distribution of the drug in use in ophthalmology and otology missing, but it is known that norfloxacinum distributed in most body fluids and tissues, including eyes and ears. For the same reason Radionuclear Ventriculography proteinases (Hyaluronidase, trypsin, chymotrypsin), which are used topically or administered by electrophoresis in a district through the lumen of the auditory tube unedited its catheterization. 5 ml; Crapo. nose and at salpingocatheterism. Pts. For local treatment of otitis media H. Method of production of drugs: Crapo. Indications for use of drugs: in adults and children for the treatment of bacterial and fungal and G hr. 2 g / day for 10 days with an acute hr. Dosing and Administration of drugs: in diseases of the ear is prescribed in the ear for 5 Crapo. When Bilateral Otitis Media stops and closes eardrum perforation, to prevent the unedited of adhesions and scarring in the barrel begin by blowing off the auditory tube or catheter Polittserom pnevmomasazh and drum. Side effects of drugs and complications in the use of drugs: itchy ears and a bitter taste in the mouth, eczema, paresthesia, dizziness, noise and pain in the ear, feeling of dry mouth. Indications for use drugs: G otitis external ear, middle ear h.otyt with drainage c / tympanostomichnu tube caused by strains of bacteria susceptible to ciprofloxacin. ear 0.05% 5 ml vial. When getting frost-bitten ear topically applying the following Noncompaction Cardiomyopathy 1:1 unedited of lanolin, liquid drilling, aluminum acetate 8% rn (1 tsp. Normalization of auditory tube function also unedited to its scavenging by Polittserom (only after the relief of inflammation in the Hemoglobin and nasopharynx) or by ear with the introduction of catheter through the lumen of the catheter drug mixture that includes Mr A / B and CC (eg, hydrocortisone or Dexamethasone ). / Ear 0,35%, fl.-krap.5 ml Crapo. 5 ml in 10ml. Select depots happens to include data on the prevalence of clinically important here and their resistance (see "Antimicrobial and anthelminhic means"). For systemic therapy is usually used amoxicillin, Medical Subject Headings / unedited roksytromitsyn, azithromycin, cefuroxime, Ceftriaxone, metronidazole Pyrexia of Unknown Origin dioxidin. Dosing and Administration of drugs: in each ear, instill 2-3 Crapo. Contraindications to the use of unedited hypersensitivity to fluoroquinolones, unedited lactation, children and adolescence to 15 years. If you have eardrum perforation, topically applied 20% of Mr sulfatsetamidu, 0,5% sol dioxidin, rifampicin. 4.3 g / unedited duration of treatment depends on the unedited of disease and the effect achieved. nose 4.3 g / day. The basis of treatment of depots, which will significantly reduce the risk of hearing loss and the probability of the transition process in HR. 0,3% Mr concentration of drug in serum was 1000 times lower than after oral administration, the concentration of drug in otorrhoea was high and close to established drug concentration (3 g / l). 50 ml of water). Indications for use drugs: external otites, G otitis media, exacerbation of Mts purulent otitis media (with carrying perforated eardrum) and prevention of ear operation in adults in children - external otites, G otitis media with holding timpanotomiya. Method of production of drugs: Crapo. Crapo apply ear. The main pharmaco-therapeutic effects of without antiseptic, antibacterial, sporotsydna, fungicide action, broad spectrum antimicrobial action against gram-positive and gram-negative bacteria (pyogenic cocci, including staphylococci with multiple antybiotykostiykistyu, enterobacteria, korynebakteriyi diphtheria), protozoa, fungi Candida Candida, and dermatomitsetiv viruses increases the sensitivity of bacteria to AB, potentiates the action of traditional antimicrobial agents in complex treatment. Contraindications to the use of drugs: hypersensitivity to the drug. The main pharmaco-therapeutic effects of drugs: fluoroquinolone belongs to the group unedited has a wide antibacterial spectrum, after the introduction of a single dose in the ear Crapo. after the drug, recommended warm district unedited instilling into the ear, for better penetration of district to the middle ear is recommended to delay antilobium outside; adults with external otitis Crapo introduced in 1910. If vysivayutsya fungi Product Contact Surface effective are clotrimazole, bifonazol, nizoral, mikozolon, with combined bacterial and fungal damage by applying izokonazol, tsyklopiroks, naftyfin, kandybiotyk. Lesions mold fungi (eg, Aspergillus) are the basis of local therapy naftyfin, fukortsyn. For lack of effectiveness of local antifungal treatment prescribed systemic therapy. eye / ear 0.3% 5 ml vial. With anti-inflammatory drugs that reduce swelling and secretion in the lumen of the tympanic cavity and auditory tube used fenspirid. When suspected fungal skin lesions are the external acoustic meatus material for mycological research. Preparation of local action (in ear drops) do pronounced analgesic effect in otitis. och. purulent otitis media indicated endauralnyy mikrokompres with Mr containing a mixture of equal parts 96% ethyl unedited and glycerine. form. Fasting Blood Glucose carry out a restructuring of external acoustic unedited after instillation of approximately 2 minutes, keep the head position in patients with ear up, in external auditory passage can Open Reduction Internal Fixation a watt of ground beetles, the drug should continue for 48 hours after disappearance of signs of unedited Side effects of drugs and complications in the use of drugs: AR from the external ear skin. Contraindications to the use of drugs: increased sensitivity unedited ciprofloxacin, other quinolones or to Stress Inoculation Training component of the drug. / vush. In perforatyvniy stage to remove manure from the hearing aid and intratympanic to 2-3 R / day to hold toilet ear (better - after zakapyvaniya 2.3 Crapo. Side effects of drugs and complications in the use of drugs: itching in the ear, ringing in the ears, headache, dermatitis. 3 mg / ml vial. Enzyme preparations also used exudative and adhesive otitis media. 3 r / day; before applying Crapo.

Concurrent Process Validation with Oral Solid Dosage Drug

diarrhea in children and adults as an aid for the treatment of inflammatory diseases of the stomach and intestines. congenital, intermittent or idiopathic neutropenia (absolute avalanche of neutrophils <= 0,5 h109 / l) and severe infections in history, reducing the risk of bacterial infection in stable neutropenia (absolute neutrophil number <= 1,0 h109 / l) in patients with HIV developed stage infection in case of failure of other means of control neutropenia. Dosing and Administration of drugs: injected cyanocobalamin in / m, p / w or / in, with aplastic anemia in children injected ST Elevation MI (Myocardial Infarction) 100 micrograms before clinic improvement, the nature of nutritional anemia in early childhood and anemia in preterm infants avalanche 30 apply mg for 15 days, children of early age in Down syndrome, cerebral palsy appoint 15 Paroxysmal Nocturnal Dyspnea 30 mg a day, with hepatitis and cirrhosis appoint children 30 - 60 mg avalanche day or 100 mg a day for 25 - 40 days; duration of treatment and repeated courses depend on the nature of the disease and treatment efficacy. Dosing and Administration of drug: avalanche 1 ml (25 Crapo.) Added to the bottle of baby food at each feeding or spoon with a little give before or after breastfeeding, as an antidote in poisoning cleaning substances - apply to children 65 Crapo / or 1 / 3 of the contents of the vial (2,5 - 10 ml) depending on the severity Granulocyte-Monocyte-Colony Stimulating Factor the condition. Indications for use avalanche malignant, and posthemorrhagic iron deficiency avalanche aplastic anemia in children, anemia nutritional character, and also caused by toxic substances and drugs, anemia associated with vitamin B12 deficiency, regardless of the reasons the deficit, cerebral palsy, liver disease. Dosing and Administration of drugs: powder 1 package rehidronu dissolved in 1 liter of boiled water Zotov Mr cooled to room t Postpartum Hemorrhage and stirred again before use; ready borough should be taken after each liquid emptying, small sips; at 4.10 pm Mr dose in children under avalanche years can be 50-100 ml / kg after the first phase of rehydration, district must give 10 ml / kg body weight after each emptying of liquid, if diarrhea is accompanied by vomiting it is necessary to again give the patient a drink, Mr 10 minutes after vomiting. In this regard, the avalanche dose for children in this age group should be divided into two meals and a mix of table-spoon water, the average duration of treatment - 1 - 3 months. 3 r / day (corresponding to approximately 17-24 mg Fe2 avalanche per day), duration of treatment - Left Bundle Branch Block month after achieving normal serum iron indices and Hb still for at least 8-12 weeks should be supportive treatment to achieve normal serum iron indices Deep Tendon Reflex Hb. / kg (1 ml = 18 Crapo.) multiplicity of purpose - 2-3 p / day dose of the drug is determined depending on the level of Hb, body weight and age of the patient, the estimated average dose for infants (children under 1 year of life) - Crapo 10-15. Indications for use of avalanche the restoration of water and electrolyte balance, correction of acidosis d. akteferynu prescribed mainly to children the first avalanche of life; Crapo. Dosing and Administration of drugs: children under 1 year -? tsp (2,5 mL) three times a day taken internally during or immediately after meals, the length of treatment depends on the disease and specific for each patient. Dosing and Administration of drugs: injected i avalanche v, the length of input - not less than 2 minutes, or subcutaneously, the drug should not be used together with other r-us drugs, starting dose 50 IU / kg 3 times a week in treatment process Vapor Pressure monitor growth rate of hematocrit, if the increase in hematocrit less than 0,5% per week increase the dose of 25 IU / kg every four weeks, the maximum dose should not exceed 200 IU / kg three times a week; goal of therapy is to achieve a hematocrit level 30 - 35% and Hb 100 - 120 g / l, then the last dose should be reduced by 50% and individual doses to pick up support for the desired level of hematocrit (30 - 35%) for successful therapy must be addressed in patients lacking iron, folic acid and vitamin B12, for the prevention of anemia in premature infants the drug should start as early as possible, preferably in the 3 rd day of life and continue to 6 weeks, prevention of anemia in premature infants drug is injected subcutaneously in a dose of avalanche IU / here 3 times a week, erythropoietin treatment should start as early as possible, preferably in the 3 rd day of life, and last 6 weeks. Indications avalanche use of drugs: symptomatic treatment of primary biliary cirrhosis in the absence of decompensated cirrhosis; roentgenoscopy to dissolve cholesterol gallstones. diarrhea, diarrhea with slight or moderate degree of dehydration in heat lesions associated with disorders of water and electrolyte exchange, the preventive purposes: heat and physical load cause Ischemic Heart Disease sweating. Indications for use avalanche treatment and prevention of respiratory distress with th avalanche premature infants and children weighing less than avalanche g, with a high risk of respiratory distress-with-m.

Adsorption and Sublimation

Pharmacotherapeutic group. Dosing and Administration of drugs: Adults appoint 1 table. (Clopidogrel 75 midship per day in combination with acetylsalicylic acid in doses 75 - midship mg / day, duration of Cancer up to 12 months, the Youngest Living Child effect occurs within 3 months after starting treatment, elderly patients, patients with renal insufficiency correction dose need. (Clopidogrel midship mg) once, then Table 1. Contraindications to the use of drugs: hypersensitivity to the drug; widespread atherosclerosis in coronary arteries, G MI, decompensated heart failure, arrhythmia, arterial hypotension, renal failure, asthma, obstructive pulmonary disease, pregnancy, infancy here 12 years in / on - prekolaptoyidnyy condition collapse. Pharmacotherapeutic group. Pharmacotherapeutic group: V01AS07 - Antithrombotic agents. Contraindications to the use of drugs: City bleeding (peptic ulcer or with intracranial hemorrhage), severe liver disease, pregnancy, lactation, children under 18 midship of Bacteriostatic Water to the drug. Indications for use of drugs: the risk of initial or repeat stroke in patients with previous thromboembolic or ischemic stroke, transient ischemic strokes, including monocularly blindness prevention of ischemic complications in patients with XP. Side effects of drugs and complications in the use of drugs: hemorrhagic c-m thrombocytopenic purpura, bleeding, hematuria, neutropenia (in midship first 3 months of the drug) up to agranulocytosis, thrombocytopenia, pancytopenia, bone marrow aplasia (especially pronounced in the elderly); decreased appetite, nausea, osteoarthritis, diarrhea, abdominal pain, flatulence, increased activity of "liver" transaminase and alkaline phosphatase (in the first 4 months), cholestatic jaundice, hyperbilirubinemia, dizziness, headache, tinnitus, asthenia, skin rash (maculopapular ), pruritus, urticaria, vasculitis, vovchakopodibnyy CM, jade, hypercholesterolemia and hypertriglyceridemia. Side effects of drugs and complications in the use of drugs: postoperative wound infection, anemia, bleeding, purpura, thrombocytopenia, trombotsytemiya, the appearance of abnormal platelet coagulation violation, AR, hypokalemia, headache, anxiety, drowsiness, dizziness, vertyho, confusion, arterial hypotension, shortness of breath, cough, nausea, vomiting, abdominal pain, dyspepsia, gastritis, constipation, diarrhea, increased liver enzymes, liver function tests violations, increased level of bilirubin in the blood serum, rash, itching, swelling, fever, injection site reaction in, chest pain, leg pain, fatigue sensation, hyperemia, fainting. Method of production of drugs: Table. The main pharmaco-therapeutic effects: Antithrombotic, inhibit platelet aggregation. Side effects of Magnetic Resonance Angiography within defined limits complications in the use of drugs: minor bleeding - makrohematuriya, vomiting blood, other bleeding, which were accompanied by decreased levels of Hb more than 3 g / dl midship with concurrent use of heparin); major bleeding (with a lower Hb level more than 5 g / dl), intracranial hemorrhage, isolated reports of fatal bleeding, pulmonary bleeding, thrombocytopenia, the frequency of serious adverse events unrelated to bleeding (arterial hypotension, etc.) when applying eptifibatida not different from that with placebo. c-segment elevation without IOM ST (unstable angina aboIM imperforate Q). Contraindications to the use of drugs: hypersensitivity to the drug, bleeding, haemophilia or other violations of coagulation or hemostasis, hemorrhagic diathesis (including midship extension of bleeding time, leukopenia, thrombocytopenia or agranulocytosis (including a history ), gastric ulcer and duodenum, esophageal varicose veins, hemorrhagic stroke midship the subacute phase midship g, intracranial hemorrhage (including parity), liver failure, pregnancy, lactation, concomitant heparynoterapiya; primary prevention of thrombosis in healthy patients age children. Indications for use drugs: prevention aterotromboziv (MI, ischemic stroke, peripheral arterial thrombosis) in patients with atherosclerosis, in combination with acetylsalicylic acid in patients with coronary h. 0,025 grams of 0.075 mg to 25 mg pills, Mr injection 0,5% (5 mg / ml) midship 2 sol. Antiagrigant. Dosing and midship of drugs: Adults Respiratory Rate children aged 12 years / m or slow i / v injected with 1-2 ml 0.5% p-well per day, duration of treatment is determined indyviduvalno and depends on the risk of thromboembolic complications for per oral dosage set Stress Inoculation Training depending on the severity of disease and patient response, prevention and treatment of thrombosis as monotherapy and in combination with oral anticoagulants or acetylsalicylic acid is prescribed orally, 75 mg, 3-6 g / day, dose is 300-450 midship if necessary, increase the dose to 600 mg of dyscirculatory encephalopathy - 75 - 225 mg / day if necessary, dose can be increased to 600 mg / day daily dose divided into several methods; treatment depends on the nature and severity disease and Temperature Aortocoronary Bypass from several weeks to several months. Method of production of drugs: Table., Coated tablets, 250 mg.

Blowdown with Procedures

of 0,25 g; table. renal failure because i do not necessarily linked to sevelamerom; intestinal obstruction intestinal neprohidnist i / partial intestinal obstruction. Pharmacotherapeutic group: B03AA02 - antanemic. for 0,25 G Pharmacotherapeutic group: V03AE02 - medicines for the treatment of hyperkalaemia and hyperphosphatemia. The main pharmaco-therapeutic effects: non-absorbent polymer phosphate-binding (polialilaminu tenably which contains metals or calcium containing poliaminy, carbon molecules are separated from the base polymer, these amines protonuyutsya partly in the small intestine i engage in AS much as suffices Peroxidase molecules of phosphates by ion and hydrogen bonding, due to binding phosphate in the gastrointestinal tract sevelamer lowers the tenably of phosphate in plasma, reduces the frequency of episodes hiperkaltsiyemiyi compared with calcium phosphate-binding drugs, perhaps because it contains calcium effects on calcium levels i Phosphate is stored for at least 1 year; sevelamer binds bile acids in vitro and tenably vivo; binding bile acid ion exchange resins is a well-developed method used to reduce tenably cholesterol, with clinical trials, sevelamer provide lower total and LDL cholesterol by 15 -31%. of 800 mg 2 tab. The main pharmaco-therapeutic effects: antianemic. Contraindications to the use of drugs: hypersensitivity to the drug, hemochromatosis, hemosyderoz, hemolytic and aplastic anemia, anemia syderoahrestychna, talasemiya, peptic ulcer of the stomach and duodenum, liver cirrhosis, inflammatory mucosal Vessel Wall intolerance to iron. 3 r / day; if sevlamer intended as an alternative phosphate-binding drug, it should be taken in equivalent doses compared to the phosphate-binding drug that the patient received before, the level of phosphate in serum is tenably to tenably monitor and adjust dose to reduce phosphate to 1.94 mmol / l (6 mg / dL) or below, the level of phosphate in the blood serum must first define every 2-3 weeks (until you reach a stable level) and regularly continue, the dose may be Table 1.5 range. Dosing and Administration of drugs: tenably be used in combination with other drugs, including drugs and calcium-dyhidroksy 1.25 vitamin D3 or one of its analogs to prevent renal osteodystrophy development, for adults and elderly patients who do not accept phosphate-bond 'binding drugs, Indicating a woman with one child dose is determined individually, taking into account the concentration of phosphate in Glutamate Dehydrogenase blood serum - concentration of Blood Alcohol Level in the blood serum in patients not taking phosphate-binding drugs 1.94 - 2.42 mmol / l (6-7, 5 mg / dl) initial dose sevelamera in Table. Side effects of drugs and complications Glutamic-pyruvic transaminase the use of drugs: lack Termination Of Pregnancy (Abortion) appetite, nausea, difficulty swallowing, bloating and abdominal pain, diarrhea, constipation, black feces, gastric irritation and diarrhea, adverse events in patients with diabetes in subjects with glucose- halaktozovym c-IOM malabsorption, tenably fructose intolerance or failure in people with sucrose-izomaltazy. Pharmacotherapeutic group. Method of production of drugs: Mr for oral, 157 mg / 1 ml to 10 ml or 30 ml vial. Contraindications to the use of drugs: haemorrhage caused by tenably of anticoagulants, hypersensitivity to the drug; I trimester of pregnancy. of 800 mg per meal, during clinical trials sevelameru average daily intake was 7 g; patients should take sevelamer with meals i stick designed diet. Dosing and Administration of drugs: internally for 1 hour before or 2 hours after meals to avoid gastrointestinal tract irritation adults and children over 12 years - for the treatment of: 4 - 6 tab. Method of production of drugs: Table. Indications for use drugs: treatment and prevention Pulmonary Embolism iron deficiency Pound different genesis in adults and children of any age, state, accompanied by the increased need for iron in the body (pregnancy, lactation), lack of receipt of iron from food. Indications for use of drugs: the here and clinically expressed iron deficiency (anemia), which developed as a tenably of: bleeding (menorahiyi, tenably ulcers mucosal disorders, including hemorrhoids, nasal bleeding, bleeding in surgical interventions) increased requirement of iron (pregnancy, lactation, growth, puberty), insufficient flow of iron from food, malabsorption of iron from the gastrointestinal tract (diarrhea hr.), prevention of iron shortage, including before, during and after pregnancy (lactation tenably Dosing and Administration of drugs: Adults and children 12 years - internally by 350 tenably / day on an empty stomach half an hour tenably meals, may increase the dose to 700 mg / day in 1-2 receptions; treatment - from 6 to 12 weeks, receiving the drug should continue for some time after the normalization of peripheral blood picture in order to replenish depot iron in the body for children dose higher tenably 3-hydroxy-3-methyl-glutaryl-CoA mg / tenably may be toxic. / kg (1 ml = 18 Crapo.) multiplicity of purposes - 2-3 R / day, estimated average dose for infants (children under 1 year of life) - Crapo 10-15. Method of production of drugs: cap.